Source: Entrepreneur
India’s longevity-focused health-tech ecosystem continues to attract strong investor interest as Bengaluru-based Biopeak secured USD 2.7 million in a follow-on funding round led by NKSquared, the investment arm of Zerodha co-founder Nikhil Kamath.
This marks Kamath’s second investment in the startup, following his USD 1.43 million funding in August 2024, reinforcing confidence in Biopeak’s AI-led preventive healthcare model.
Funds to Drive Expansion, New Clinic, and AI Capabilities
Biopeak plans to deploy the fresh capital across geographic expansion, infrastructure development, and technology enhancement. The company will open a second physical clinic, strengthen diagnostic and imaging capabilities, and invest further in its proprietary AI systems to deliver more profound, more precise health insights.
The funding will also support clinical research, protocol development, and new health optimisation programs, enabling Biopeak to standardise and scale its longevity offerings across multiple cities.
Founders and Vision Behind Biopeak
Founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak was built on the belief that India’s healthcare system needs to shift from reactive treatment to proactive, preventive care. The startup positions itself as a long-term health partner rather than a one-time diagnostics provider.
By adopting a “family health office” model, Biopeak delivers continuous health monitoring, personalised interventions, and long-term wellness planning through a single integrated platform.
Technology-Driven Longevity and Preventive Care Model
At the core of Biopeak’s offering is its AI-powered diagnostics engine, which combines molecular testing, imaging, and lifestyle data to generate actionable insights. The platform integrates organic acid profiling, microbiome mapping, whole-exome functional genomics, salivary cortisol rhythm analysis, along with advanced imaging modalities such as MRI, CT, DXA, and ECHO.
These insights enable clinicians to design personalised plans focused on nutrition, sleep optimisation, stress management, metabolic health, and early disease detection.
Targeting High Achievers and Women-Centric Health Programs
Biopeak primarily serves high-performing professionals, business leaders, and women, offering tailored programs that address gender-specific and lifestyle-driven health risks. Its approach blends wearable data, specialist-led care teams, and AI-driven recommendations calibrated for Indian genetics, biology, and disease trends.
The company’s emphasis on structured, long-term health management has resonated with clients seeking comprehensive and preventive solutions beyond conventional diagnostics.
Growing Demand Fuels Clinic Expansion Plans
India is witnessing growing awareness around longevity, healthspan optimisation, and preventive care, particularly among urban professionals. Over the past year, Biopeak has expanded both its client base and clinical offerings, reflecting this shift in consumer behaviour.
Following the launch of its first clinic in Bengaluru last year, Biopeak is set to open its second clinic in the coming month, with plans to enter additional metro markets as demand scales.
NKSquared’s continued backing of Biopeak highlights increasing investor interest in clinic-led, technology-enabled healthcare models. As India’s health-tech sector evolves, startups combining AI, diagnostics, and personalised care are emerging as key growth drivers.
With fresh capital and strategic investor support, Biopeak is positioning itself to become a significant player in India’s next-generation preventive and longevity healthcare landscape.
